CDKN2A and neoplasm: Under the same conditions, injection of cdkn2a/b-TALEN mRNA led to an increase in tumor incidence frequency up to about 39% and accelerated tumor onset as early as 35 to 37 wpf in tp53e7/e7 mutant zebrafish (Table 1).